Ido expression by dendritic cells: tolerance and tryptophan catabolism
Top Cited Papers
- 1 October 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 4 (10), 762-774
- https://doi.org/10.1038/nri1457
Abstract
Indoleamine 2,3-dioxygenase (IDO) is an enzyme that degrades the essential amino acid tryptophan. The concept that cells expressing IDO can suppress T-cell responses and promote tolerance is a relatively new paradigm in immunology. Considerable evidence now supports this hypothesis, including studies of mammalian pregnancy, tumour resistance, chronic infections and autoimmune diseases. In this review, we summarize key recent developments and propose a unifying model for the role of IDO in tolerance induction.Keywords
This publication has 148 references indexed in Scilit:
- Dendritic cells: the immune information management expertsNature Immunology, 2004
- Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftmentHuman Immunology, 2004
- Dendritic cells: emerging pharmacological targets of immunosuppressive drugsNature Reviews Immunology, 2004
- Natural versus adaptive regulatory T cellsNature Reviews Immunology, 2003
- An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative StressMolecular Cell, 2003
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Global and Specific Translational Control by Rapamycin in T Cells Uncovered by Microarrays and ProteomicsJournal of Biological Chemistry, 2002
- TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive MilieuImmunity, 2001
- Induction of Tryptophan 2,3-Dioxygenase in the Mouse Endometrium during ImplantationBiochemical and Biophysical Research Communications, 2000
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999